These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

789 related articles for article (PubMed ID: 20159883)

  • 61. Prevalence of Polycystic Ovary Syndrome in Patients With Pediatric Type 2 Diabetes: A Systematic Review and Meta-analysis.
    Cioana M; Deng J; Nadarajah A; Hou M; Qiu Y; Chen SSJ; Rivas A; Banfield L; Alfaraidi H; Alotaibi A; Thabane L; Samaan MC
    JAMA Netw Open; 2022 Feb; 5(2):e2147454. PubMed ID: 35166782
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Incidence and prevalence of diabetes and cost of illness analysis of polycystic ovary syndrome: a Bayesian modelling study.
    Ding T; Hardiman PJ; Petersen I; Baio G
    Hum Reprod; 2018 Jul; 33(7):1299-1306. PubMed ID: 29684121
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Low prevalence of the metabolic syndrome but high occurrence of various metabolic disorders in Chinese women with polycystic ovary syndrome.
    Ni RM; Mo Y; Chen X; Zhong J; Liu W; Yang D
    Eur J Endocrinol; 2009 Sep; 161(3):411-8. PubMed ID: 19542239
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Analysis of clinical characteristics in large-scale Chinese women with polycystic ovary syndrome.
    Shi Y; Guo M; Yan J; Sun W; Zhang X; Geng L; Xu L; Chen Z
    Neuro Endocrinol Lett; 2007 Dec; 28(6):807-10. PubMed ID: 18063948
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Heterogeneity of gestational diabetes (GDM) and long-term risk of diabetes and metabolic syndrome: findings from the RADIEL study follow-up.
    Huvinen E; Eriksson JG; Koivusalo SB; Grotenfelt N; Tiitinen A; Stach-Lempinen B; Rönö K
    Acta Diabetol; 2018 May; 55(5):493-501. PubMed ID: 29460080
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Incidence of prediabetes and risk of developing cardiovascular disease in women with polycystic ovary syndrome.
    Velija-Asimi Z; Burekovic A; Dujic T; Dizdarevic-Bostandzic A; Semiz S
    Bosn J Basic Med Sci; 2016 Nov; 16(4):298-306. PubMed ID: 27648989
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Polycystic Ovary Syndrome Signs and Metabolic Syndrome in Premenopausal Hispanic/Latina Women: the HCHS/SOL Study.
    Meyer ML; Sotres-Alvarez D; Steiner AZ; Cousins L; Talavera GA; Cai J; Daviglus ML; Loehr LR
    J Clin Endocrinol Metab; 2020 Mar; 105(3):e447-56. PubMed ID: 31917455
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Prevalence of the metabolic syndrome and its components: findings from a Finnish general population sample and the Diabetes Prevention Study cohort.
    Ilanne-Parikka P; Eriksson JG; Lindström J; Hämäläinen H; Keinänen-Kiukaanniemi S; Laakso M; Louheranta A; Mannelin M; Rastas M; Salminen V; Aunola S; Sundvall J; Valle T; Lahtela J; Uusitupa M; Tuomilehto J;
    Diabetes Care; 2004 Sep; 27(9):2135-40. PubMed ID: 15333474
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Racial and ethnic differences in the prevalence of metabolic syndrome and its components of metabolic syndrome in women with polycystic ovary syndrome: a regional cross-sectional study.
    Chan JL; Kar S; Vanky E; Morin-Papunen L; Piltonen T; Puurunen J; Tapanainen JS; Maciel GAR; Hayashida SAY; Soares JM; Baracat EC; Mellembakken JR; Dokras A
    Am J Obstet Gynecol; 2017 Aug; 217(2):189.e1-189.e8. PubMed ID: 28400308
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Insulin sensitivity and beta cell function in different glucose tolerance status].
    Gómez-García A; Magaña-Garns P; Ruiz-García J; Alvarez-Aguilar C
    Invest Clin; 2006 Jun; 47(2):155-66. PubMed ID: 16886777
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Association of hypovitaminosis D with metabolic disturbances in polycystic ovary syndrome.
    Wehr E; Pilz S; Schweighofer N; Giuliani A; Kopera D; Pieber TR; Obermayer-Pietsch B
    Eur J Endocrinol; 2009 Oct; 161(4):575-82. PubMed ID: 19628650
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The association between metabolic syndrome and polycystic ovary syndrome: A systematic review and meta-analysis.
    Otaghi M; Azami M; Khorshidi A; Borji M; Tardeh Z
    Diabetes Metab Syndr; 2019; 13(2):1481-1489. PubMed ID: 31336510
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The Impact of Obesity on the Incidence of Type 2 Diabetes Among Women With Polycystic Ovary Syndrome.
    Kakoly NS; Earnest A; Teede HJ; Moran LJ; Joham AE
    Diabetes Care; 2019 Apr; 42(4):560-567. PubMed ID: 30705063
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Antimüllerian hormone levels and cardiometabolic risk in young women with polycystic ovary syndrome.
    Feldman RA; O'Neill K; Butts SF; Dokras A
    Fertil Steril; 2017 Jan; 107(1):276-281. PubMed ID: 27842995
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Polycystic ovary syndrome and abnormalities in glucose tolerance.
    Bhattacharya SM
    Int J Gynaecol Obstet; 2009 Apr; 105(1):29-31. PubMed ID: 19155002
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Prevalence of polycystic ovary syndrome in reproductive-aged women with type 2 diabetes.
    Amini M; Horri N; Farmani M; Haghighi S; Sattari G; Pornaghshband Z; Aminorroaya A
    Gynecol Endocrinol; 2008 Aug; 24(8):423-7. PubMed ID: 18850378
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome.
    Ehrmann DA; Liljenquist DR; Kasza K; Azziz R; Legro RS; Ghazzi MN;
    J Clin Endocrinol Metab; 2006 Jan; 91(1):48-53. PubMed ID: 16249284
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Risk factors for glucose intolerance in Danish women with polycystic ovary syndrome.
    Trolle B; Lauszus FF
    Acta Obstet Gynecol Scand; 2005 Dec; 84(12):1192-6. PubMed ID: 16305707
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Obesity is the predominant predictor of impaired glucose tolerance and metabolic disturbance in polycystic ovary syndrome.
    Liang SJ; Liou TH; Lin HW; Hsu CS; Tzeng CR; Hsu MI
    Acta Obstet Gynecol Scand; 2012 Oct; 91(10):1167-72. PubMed ID: 22497305
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Glucose intolerance, insulin resistance and cardiovascular risk factors in first degree relatives of women with polycystic ovary syndrome.
    Yilmaz M; Bukan N; Ersoy R; Karakoç A; Yetkin I; Ayvaz G; Cakir N; Arslan M
    Hum Reprod; 2005 Sep; 20(9):2414-20. PubMed ID: 15890734
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 40.